• 1
    Henderson NC, Iredale JP. Liver fibrosis: cellular mechanisms of progression and resolution. Clin Sci (Lond) 2007; 112:265280.
  • 2
    Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008; 134:16551669.
  • 3
    Kisseleva T, Brenner DA. Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis. J Gastroenterol Hepatol 2007; 22 (Suppl. 1):P7378.
  • 4
    Thomson BJ. Hepatitis C virus: the growing challenge. Br Med Bull 2009; 89:153167.
  • 5
    Brown KS, Keogh MJ, Tagiuri N et al. Severe fibrosis in hepatitis C virus-infected patients is associated with increased activity of the mannan-binding lectin (MBL)/MBL-associated serine protease 1 (MASP-1) complex. Clin Exp Immunol 2007; 147:9098.
  • 6
    Thiel S. Complement activating soluble pattern recognition molecules with collagen-like regions, mannan-binding lectins, ficolins, and associated proteins. Mol Immunol 2007; 44:38753888.
  • 7
    Gal P, Harmat V, Kocsis A et al. A true autoactivating enzyme. Structural insight into mannose-binding lectin-associated serine protease-2 activations. J Biol Chem 2005; 280:3343533444.
  • 8
    Heja D, Kocsis A, Dobo J et al. Revised mechanism of complement lectin-pathway activation revealing the role of serine protease MASP-1 as the exclusive activator of MASP-2. Proc Natl Acad Sci USA 2012; 109:1049810503.
  • 9
    Heja D, Harmat V, Fodor K et al. Monospecific inhibitors show that both mannan-binding lectin-associated serine protease-1 (MASP-1) and -2 are essential for lectin pathway activation and reveal structural plasticity of MASP-2. J Biol Chem 2012; 287:2029020300.
  • 10
    Degn SE, Jensen L, Hansen AG et al. Mannan-binding lectin-associated serine protease (MASP)-1 is crucial for lectin pathway activation in human serum, whereas neither MASP-1 nor MASP-3 is required for alternative pathway function. J Immunol 2012; 189:39573969.
  • 11
    Megyeri M, Harmat V, Major B et al. Quantitative characterisation of the activation steps of mannan-binding lectin (MBL)-associated serine proteases (MASPs) points to the central role of MASP-1 in the initiation of the complement lectin pathway. J Biol Chem 2013; 288:89228934.
  • 12
    Gulla KC, Gupta K, Krarup A et al. Activation of mannan-binding lectin-associated serine proteases leads to generation of a fibrin clot. Immunology 2010; 129:482495.
  • 13
    Hess K, Ajjan R, Phoenix F et al. Effects of MASP-1 of the complement system on activation of coagulation factors and plasma clot formation. PLoS 2012; 7:e35690. doi: 10.1371/journal.pone.0035690.
  • 14
    Marra F, DeFranco R, Grappone C et al. Expression of the thrombin receptor in human liver: up-regulation during acute and chronic injury. Hepatology 1998; 27:462471.
  • 15
    Calvaruso V, Maimone S, Gatt A et al. Coagulation and fibrosis in chronic liver disease. Gut 2008; 57:17221727.
  • 16
    Gaca MD, Zhou X, Issa R et al. Basement membrane-like matrix inhibits proliferation and collagen synthesis by activated rat hepatic stellate cells: evidence for matrix-dependent deactivation of stellate cells. Matrix Biol 2003; 22:229239.
  • 17
    Chen CB, Wallis R. Stoichiometry of complexes between mannose-binding protein and its associated serine proteases. Defining functional units of complement activation. J Biol Chem 2001; 276:2589425902.
  • 18
    Wakita T, Pietschmann T, Kato T et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005; 11:791796.
  • 19
    Lindenbach BD, Evans MJ, Syder AJ et al. Complete replication of hepatitis C virus in cell culture. Science 2005; 309:623626.
  • 20
    Terai I, Kobayashi K, Matsushita M, Fujita T. Human serum mannose-binding lectin (MBL)-associated serine protease-1 (MASP-1): determination of levels in body fluids and identification of two forms in serum. Clin Exp Immunol 1997; 110:317323.
  • 21
    Mallat A, Gallois C, Tao J et al. Platelet-derived growth factor-BB and thrombin generate positive and negative signals from human hepatic stellate cell proliferation. Role of a prostaglandin/cyclic AMP pathway and cross-talk with endothelin receptors. J Biol Chem 1998; 273:2730027305.
  • 22
    Marra F, Grandaliano G, Valente AJ et al. Thrombin stimulates proliferation of liver fat storing cells and expression of monocyte-chemotactic protein-1: potential role in liver injury. Hepatology 1995; 22:780787.
  • 23
    Megyeri M, Mako V, Beinrohr L et al. Complement protease MASP-1 activates human endothelial cells: PAR4 activation is a link between complement and endothelial function. J Immunol 2009; 183:34093416.
  • 24
    Schlapbach LJ, Mattmann M, Thiel S et al. Differential role of the lectin pathway of complement activation in susceptibility to neonatal sepsis. Clin Infect Dis 2010; 15:153162.
  • 25
    Azad AK, Sadee W, Schlesinger LS. Innate immune gene polymorphisms in tuberculosis. Infect Immun 2012; 80:33433359.
  • 26
    Ali YM, Lynch NJ, Haleem KS et al. The lectin pathway of complement activation is a critical component of the innate immune response to pneumococcal infection. PLoS Pathog 2012; 8:e1002793.
  • 27
    Zhang S, Kodys K, Babcock GJ, Szabo G. CD81/CD9 tetraspanins aid plasmacytoid dendritic cells in recognition of HCV-infected cells and induction of IFNα. Hepatology 2012. doi: 10.1002/hep.25827.
  • 28
    Zhang S, Kodys K, Li K, Szabo G. Human type 2 myeloid dendritic cells produce interferon-λ and amplify interferon-α in response to hepatitis C virus infection. Gastroenterology 2013; 144:414425.
  • 29
    Tarr AW, Urbanowicz RA, Ball JK. The role of humoral innate immunity in hepatitis C virus infection. Viruses 2012; 4:127.
  • 30
    Iacob RE, Perdivara I, Przybylski M et al. Mass spectrometric characterization of glycosylation of hepatitis C virus E2 envelope glycoprotein reveals extended microheterogeneity of N-glycans. J Am Soc Mass Spectrom 2008; 19:428444.
  • 31
    Liu J, Ali MA, Shi Y et al. Specifically binding of L-ficolin to N-glycans of HCV envelope glycoproteins E1 and E2 leads to complement activation. Cell Mol Immunol 2009; 6:235244.
  • 32
    Brown K, Keogh MJ, Owsianka AM et al. Specific interaction of hepatitis C virus glycoproteins with mannan binding lectin inhibits virus entry. Protein Cell 2010; 1:664674.
  • 33
    Blackham S, Baillie A, Al-Hababi F et al. Gene expression profiling indicates the roles of host oxidative stress, apoptosis, lipid metabolism, and intracellular transport genes in the replication of hepatitis C virus. J Virol 2010; 84:54045414.
  • 34
    Tulio S, Faucz FR, Werneck RI et al. MASP2 gene polymorphism is associated with susceptibility to hepatitis C virus infection. Hum Immunol 2011; 72:912915.
  • 35
    Eurich D, Boas-Knoop S, Morawietz L et al. Association of mannose-binding lectin-2 gene polymorphism with the development of hepatitis C-induced hepatocellular carcinoma. Liver Int 2011; 31:10061012.
  • 36
    Dobo J, Harmat V, Beinrohr L, Sebestyen E, Zavodsky P, Gal P. MASP-1, a promiscuous complement protease: structure of its catalytic region reveals the basis of its broad specificity. J Immunol 2009; 183:12071214.